Current and Former Awardees


2024 Recipients

Rahul S. Bhansali, MD
"Investigating chromatin architectural dynamics mediated by LDB1 in T-cell acute lymphoblastic leukemia" at University of Pennsylvania
Xiaoli Mi, MD
"Origin and evolution of long-lived CAR T cells in patients with hematologic malignancies" at Memorial Sloan Kettering Cancer Center
Vignesh Shanmugam, MD
"Uncovering microenvironmental dependencies in follicular lymphoma" at Brigham and Women's Hospital
Rebecca L. Zon, MD
"Defining the mechanism of thrombosis in patients with multiple myeloma" at Dana-Farber Cancer Institute

2023 Recipients

Nicole M. Cruz, MD
"Understanding the role of KMT2D in MLL-AF9 acute myeloid leukemia" at The Rockefeller University
Mounica Vallurupalli, MD
"Defining the mechanistic implications of SF3B1 mutations in MDS" at Dana-Farber Cancer Institute
Nina Weichert-Leahey, MD
"Elucidating the role of KAT6A and KAT6B in the epigenetic reprogramming of neuroblastoma to enforce neuronal differentiation" at Dana-Farber Cancer Institute

2022 Recipients

Wallace A. Bourgeois, MD
"Targeting JMJD1C and IKZF1 as therapeutic opportunities in KMT2A-rearranged leukemia" at Dana-Farber Cancer Institute
Mark B. Leick, MD
"Engineering novel CAR T cells for AML: translating lessons from correlative studies and other diseases" at Massachusetts General Hospital
Mira A. Patel, MD
"Molecular mechanisms of human APOE-mediated myeloid cell modulation in cancer" at The Rockefeller University

2021 Recipients

Caitlin F. Bell, MD
"Smooth muscle cell plasticity in the tumor microenvironment: another parallel between atherosclerosis and cancer" at Stanford University School of Medicine
Albert E. Kim, MD
"Using liquid biopsy and MRI to non-invasively identify therapeutic targets for brain metastases" at Massachusetts General Hospital
(Peter) Geon Kim, MD
"Elucidating the mechanisms of inflammation in clonal hematopoiesis" at Dana-Farber Cancer Institute
Max M. Wattenberg, MD
"Epigenetic reprogramming of dendritic cells for cancer immunotherapy" at University of Pennsylvania

2020 Recipients

Elisa A. Aquilanti, MD
"Targeting telomerase in glioblastoma" at Dana-Farber Cancer Institute
Jonathan C. Dudley, MD
"Earlier detection of cancer in body cavity fluids through aneuploidy analysis after cell enrichment and partitioning" at The Johns Hopkins University School of Medicine
Dennis J. Hsu, MD
"Metabolic determinants of codon usage bias in colorectal cancer" at University of Pittsburgh
Andrew L. Ji, MD
"Cancer cell-extrinsic and intrinsic control of tumor progression and intratumoral heterogeneity" at Stanford University School of Medicine
Natalie Vokes, MD
"Dissecting tumor intrinsic and immune drivers of resistance to therapy in non-small cell lung cancer" at The University of Texas MD Anderson Cancer Center

2019 Recipients

Edmond M. Chan, MD
"Validating a novel synthetic lethal target for microsatellite unstable cancers" at Dana-Farber Cancer Institute
Andrew J. Dunbar, MD
"Interrogating functional contribution of JAK2V617F in the maintenance of myeloproliferative neoplasms" at Memorial Sloan Kettering Cancer Center
Gabriel K. Griffin, MD
"Enhancing cancer immunotherapy through epigenetic modulation of the repetitive genome" at Brigham and Women's Hospital
Ashley K. Koegel, MD
"Engineering next generation CAR T cells to treat AML: enhancing safety through dynamic control and specificity" at University of California, San Francisco
Jonathan E. Shoag, MD
"Harnessing clinical data to identify new prostate cancer therapeutics" at University Hospitals Cleveland Medical Center
Rabi Upadhyay, MD
"Determining the distal effects of gut microbiota on the lung tumor microenvironment, cancer progression, and checkpoint blockade efficacy" at NYU Grossman School of Medicine

2018 Recipients

Nicholas C. DeVito, MD
"Investigating the role of EMT-mediated dendritic cell tolerization in checkpoint inhibitor resistance" at Duke University
John R. Ferrarone, MD
"Seeking and evaluating novel therapeutic targets in human lung adenocarcinomas with loss-of-function mutations in LKB1" at Weill Cornell Medicine
Lillian M. Guenther, MD
"Investigation of CITED2 as a novel dependency in Ewing sarcoma" at St. Jude Children's Research Hospital
David Liu, MD
"Dissecting differential therapy response in melanoma through clinical computational oncology" at Dana-Farber Cancer Institute
Harshabad Singh, MBBS
"Epigenetic evolution of pancreatic adenocarcinoma during combination chemotherapy" at Dana-Farber Cancer Institute

2017 Recipients

Jennifer L. Caswell-Jin, MD
"Breast cancer evolution and resistance in response to HER2-targeted therapy" at Stanford University
Christopher J. Gibson, MD
"The biology and clinical implications of clonal hematopoiesis in cancer patients" at Dana-Farber Cancer Institute
Melody Smith, MD
"CD19 targeted donor T cells improve graft versus tumor activity and reduce graft versus host disease" at Memorial Sloan Kettering Cancer Center
Sakiko Suzuki, MD
"Inflammatory cell death pathways in Myelodysplastic Syndromes" at University of Massachusetts Medical School

2016 Recipients

Giada Bianchi, MD
"Molecular mechanisms of ROBO1 in multiple myeloma pathogenesis" at Dana-Farber Cancer Institute
Kristopher R. Bosse, MD
"GPC2 as an oncogene and immunotherapeutic target in high-risk neuroblastoma" at Children's Hospital of Philadelphia
Julia C. Carnevale, MD
"Developing new therapeutic approaches for pancreatic cancer with homologous recombination repair defects" at University of California, San Francisco
Michael W. Drazer, MD
"Defining leukemogenic mechanisms in hereditary hematologic malignancies" at The University of Chicago
David M. Kurtz, MD, PhD
"Response prediction and personalized therapy from mathematical modeling of circulating tumor DNA in non-Hodgkin lymphoma" at Stanford University

2015 Recipients

Pavan Bachireddy, MD
"Coevolution of tumor and T cell heterogeneity following immunotherapy" at Dana-Farber Cancer Institute
Carolyn C. Jackson, MD, MPH
"Genetic dissection of pediatric classic Kaposi sarcoma" at Memorial Sloan Kettering Cancer Center
Loretta S. Li, MD
"Mechanisms of disease and resistance in CRLF2-rearranged B-cell acute lymphoblastic leukemia" at Dana-Farber Cancer Institute
  • You can support our innovative researchers.